Gigant B, Cormier A, Dorléans A, Ravelli R B G, Knossow M
Laboratoire d'Enzymologie et Biochimie Structurales (LEBS), CNRS, Bat. 34, 1 avenue de la Terrasse, 91198, Gif-sur-Yvette, France,
Top Curr Chem. 2009;286:259-78. doi: 10.1007/128_2008_11.
Microtubules (MTs) are dynamic structures of the eukaryotic cytoskeleton that, during cell division, form the mitotic spindle. Perturbing them leads to mitotic arrest and ultimately to cell death. Consistently, MTs and their building block, αβ tubulin, are one of the best characterized targets in anti-cancer chemotherapy. Drugs that interfere with MTs either stabilize or destabilize them. The latter class is the subject of this review. These ligands bind to the colchicine site or to the vinca domain, two distinct sites located at a distance from each other on tubulin. Nevertheless the effects of both classes of ligands share a common theme, they prevent the formation of MT specific contacts, therefore triggering their disassembly.
微管(MTs)是真核细胞骨架的动态结构,在细胞分裂期间形成有丝分裂纺锤体。干扰它们会导致有丝分裂停滞并最终导致细胞死亡。一致地,微管及其组成成分αβ微管蛋白是抗癌化疗中特征最明确的靶点之一。干扰微管的药物要么使其稳定,要么使其不稳定。后一类是本综述的主题。这些配体与秋水仙碱结合位点或长春花结构域结合,这两个不同的位点在微管蛋白上彼此相距一定距离。然而,这两类配体的作用有一个共同的主题,即它们阻止微管特异性接触的形成,从而引发其解聚。